A Novel Approach to Manage Hypercholesterolemia: Veterans Affairs Lipid Optimization Reimagined Quality Improvement

Luc Djousse1, Rachel E Ward2, Helen Marucci-Wellman2

  • 1MAVERIC, Boston VA Healthcare System, Boston, MA, USA; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

JACC. Advances
|June 18, 2026
PubMed

Insights

Lipid optimization strategies improved low-density lipoprotein cholesterol (LDL-C) control in veterans with atherosclerotic cardiovascular disease (ASCVD). Tailored interventions increased LDL-C goal achievement and medication adherence.

Area of Science:

  • Cardiovascular Medicine
  • Public Health
  • Quality Improvement

Background:

  • Elevated low-density lipoprotein cholesterol (LDL-C) is a primary risk factor for atherosclerotic cardiovascular disease (ASCVD).
  • Despite available treatments, LDL-C goals are unmet in a majority of veterans with ASCVD.
  • Current lipid management strategies require optimization for improved patient outcomes.

Purpose of the Study:

  • To evaluate the effectiveness of tailored lipid optimization strategies in improving LDL-C control among veterans.
  • To assess the impact of these strategies on the utilization and patient adherence to lipid-lowering therapy (LLT).
  • To identify site-specific barriers and implement targeted interventions for enhanced lipid management.

Main Methods:

  • A quality improvement program involving 167,505 veterans with prevalent ASCVD across 50 Veterans Affairs Medical Centers.
  • Collaboration between American Heart Association consultants and local providers to identify and address barriers to lipid management.
  • Primary outcome measured was the proportion of veterans achieving an LDL-C <70 mg/dL at 24 months.

Main Results:

  • 34.4% of veterans achieved the LDL-C goal (<70 mg/dL) at 24 months, a significant improvement (P < 0.001).
  • Mean LDL-C levels decreased by 16.6 mg/dL.
  • Use of LLT increased from 77.4% to 87.8%, and adherence to LLT rose from 56.3% to 65.1%.

Conclusions:

  • Addressing site-specific barriers to lipid management effectively improves LDL-C control in veterans with ASCVD.
  • Tailored interventions are crucial for enhancing lipid-lowering therapy utilization and adherence.
  • This quality improvement initiative demonstrates a successful model for optimizing cardiovascular risk management in a veteran population.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...